| Literature DB >> 30205795 |
Anna Aiello1, Giuseppina Candore1, Giulia Accardi1, Calogero Caruso1, Claudia Colomba2, Giovanni Duro3, Caterina Maria Gambino1, Mattia Emanuela Ligotti1, Danilo Di Bona4.
Abstract
Killer immunoglobulin-like receptors (KIRs) regulate the activation of natural killer cells through their interaction with human leucocyte antigens (HLA). KIRs and HLA loci are highly polymorphic, and some of their combinations have been found to protect against viral infections or to predispose to autoimmune disorders. In particular, some activating KIRs profiles may be detrimental in autoimmune pathogenesis, and specific KIRs may be particularly aggressive in the clearance of different microorganisms, protecting individuals in the control of a given pathogen. So, considering that in the pathogenesis of many autoimmune disorders and infections innate immunity plays a key role, the recent development for KIRs characterization, diseases monitoring, and treatment becomes obvious. Here, we reviewed a growing body of evidence supporting the influence of KIRs variants and their interaction with ligands in the development of the main human autoimmune and viral diseases, highlighting the main applications in clinical practice. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.Entities:
Keywords: Autoimmune diseases; HLA ligands; KIRs; immunogenetics; translational medicine; viral infections.
Mesh:
Substances:
Year: 2018 PMID: 30205795 DOI: 10.2174/1381612824666180911123249
Source DB: PubMed Journal: Curr Pharm Des ISSN: 1381-6128 Impact factor: 3.116